Decision Diagnostics' Board Votes to Uplist to OTC QX Company Engages Sponsoring Brokerage and Designated Advisor for Disclosure, and Plans Immediate Application to OTC QX, the Premier OTC Market Tier LOS ANGELES, CA -- (Marketwired) -- 12/10/13 -- Decision Diagnostics Corp. (OTCBB: DECN), the exclusive worldwide sales, service and regulatory processes agent for the popular Shasta GenStrip(TM), the unique Green Glucose Test Strip, specifically designed to work with the Johnson & Johnson's (NYSE: JNJ) LifeScan Ultra family of glucose testing meters, today announced that the company's Board of Directors has approved the company's uplisting to the OTC QX, the Premier OTC Market Tier. Concurrent with these Board Resolutions, the company has engaged a sponsoring brokerage and engaged counsel who shall serve as the company's Designated Advisor for Disclosure (DAD). Keith Berman, Principal Executive Officer of Decision Diagnostics, commented, "The uplisting to the OTC QX is an activity we have considered for some time. Our ultimate goal is to achieve a listing on NYSE MKT (formerly NYSE Amex). However, the current uplist to the premier OTC market tier will accomplish the much needed goals of allowing our stock to be quoted and traded by a wider range of brokerages, particularly retail brokers, without many of the issues we endure as a fully reporting OTC BB company. We will have more to discuss about other aspects of this uplist registration in the coming days." Interested parties may view the OTC QX web site: http://www.otcqx.com/qx/otcqx/requirements Forward-Looking Statements: This release contains forward-looking statements about our business or financial condition that reflect our assumptions and beliefs based on information currently available. We can give no assurance that the expectations indicated by such forward-looking statements will be realized. There may be other risks and circumstances that we are unable to predict. When used in this release, words such as "believes," "expects," "forecasts," "intends," "projects," "plans," "anticipates," "estimates," "will" and similar expressions are intended to identify forward-looking statements, although there may be certain statements not accompanied by such expressions. For further information about Shasta GenStrip, please visit the company's Web Sites: http://www.decisiondiagnostics.com/ or http://www.shastagenstrip.com/. The company also reminds all interested parties that the airing of its commercial video titled "GenStrip: A Patchwork of Life began on November 1 and will continue. We are currently filming additional Patchwork of Life commercials. And in the meantime the extremely popular video is available for viewing at: http://shastagenstrip.com/shasta_ad.html or http://youtu.be/zzBuHxb-rlM. GenStrip(TM) test strips are a product of Shasta Technologies, LLC and are not manufactured, distributed, endorsed, or approved by nor associated with LifeScan(R), Inc. a Johnson & Johnson(R) Company, manufacturers and distributors of the OneTouch(R) Ultra(R) Family of Meters and OneTouch(R) Ultra(R) test strips purchased prior to July 2013. Decision Diagnostics Corp. Keith Berman (805) 446-2973 firstname.lastname@example.org
Decision Diagnostics' Board Votes to Uplist to OTC QX
Press spacebar to pause and continue. Press esc to stop.